Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus Publisher



Lotfali E1 ; Ghasemi R2 ; Mardani M3 ; Fattahi A4 ; Rezaei K2 ; Toreyhi H2 ; Abolghasemi S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medial Sciences, Tehran, Iran
  4. 4. Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Clinical Infectious Diseases Published:2020


Abstract

Since late 2019, when novel coronavirus pneumonia emerged in China and spread worldwide, there has been a need for data con-cerning the clinical characteristics of infected immunocompromised patients. It has been reported that a significant mortality rate occurs in individuals with underlying comorbidities such as hematologic malignancies. Therefore, it is vital to illustrate the clinical manifestations and outcomes of COVID-19 in these vulnerable patients and identify safe therapeutic strategies. This study reviewed the clinical course, laboratory findings, and risk factors associated with hematologic malignant patients with COVID-19 along with the management and therapeutic regimens. © 2020, Author(s).
Related Docs
View other Related Docs
1. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
2. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
3. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
4. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
5. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
6. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
7. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
8. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (25)
Seyed Ahmad Seyed Alinaghi (6)
Other Related Docs
9. Interleukin-6 and Severe Covid-19: A Systematic Review and Meta-Analysis, European Cytokine Network (2020)
10. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
11. Chest-Ct Findings of Covid-19 in Patients With Pre-Existing Malignancies; a Pictorial Review, Clinical Imaging (2020)
12. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
13. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
14. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
15. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
16. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
17. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
18. Interferon Β-1B in Treatment of Severe Covid-19: A Randomized Clinical Trial, International Immunopharmacology (2020)
19. A Randomized Clinical Trial of the Efficacy and Safety of Interferon Β-1A in Treatment of Severe Covid-19, Antimicrobial Agents and Chemotherapy (2020)
20. Efficacy and Safety of Corticosteroids in Covid-19 Based on Evidence for Covid-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis; [Efficacite Et Innocuite Des Corticosteroides Dans Le Traitement De La Covid-19 Selon Des Donnees Pour La Covid-19, D’Autres Infections Aux Coronavirus, L’Influenza, La Pneumonie Extrahospitaliere Et Le Syndrome De Detresse Respiratoire Aigue: Revue Systematique Et Meta-Analyse], CMAJ (2020)
21. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
22. Association Between Serum Inflammatory Parameters and the Disease Severity in Covid-19 Patients, Journal of Clinical Laboratory Analysis (2022)
23. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
24. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
25. Efficacy and Safety of Corticosteroids in Covid-19 Based on Evidence for Covid-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis, CMAJ (2020)
26. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
27. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
28. Pregnant Women and Infants Against the Infection Risk of Covid-19: A Review of Prenatal and Postnatal Symptoms, Clinical Diagnosis, Adverse Maternal and Neonatal Outcomes, and Available Treatments, Archives of Gynecology and Obstetrics (2022)
29. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
30. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
31. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)
32. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
33. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
34. Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions, Eurasian Journal of Medicine and Oncology (2020)
35. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
36. An Overview of Possible Solutions Putting an End to the Covid-19 Pandemic, Acta Biomedica (2022)
37. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
38. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
39. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)
40. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
41. Investigating the Association Between Covid-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study, Infection# Epidemiology and Microbiology (2023)
42. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
43. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
44. Coronavirus Disease 2019 (Covid-19) in Children: Prevalence, Diagnosis, Clinical Symptoms, and Treatment, International Journal of General Medicine (2020)
45. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
46. Sars-Cov-2 and Covid-19, Evidence From a Literature Review: Review Article, Tehran University Medical Journal (2021)
47. Covid-19: General Strategies for Herbal Therapies, Journal of Evidence-Based Integrative Medicine (2022)
48. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
49. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
50. The Relationship Between Sudden Sensorineural Hearing Loss, Vestibular Neuritis, and Infection With Covid-19, Journal of Modern Rehabilitation (2021)